https://cancer.miconferences.com/ 1.0 https://cancer.miconferences.com/about/about-conference 0.9 https://cancer.miconferences.com/about/venue-accommodation 0.9 https://cancer.miconferences.com/2025 0.9 https://cancer.miconferences.com/about/general-information 0.9 https://cancer.miconferences.com/about/conference-brochure 0.9 https://cancer.miconferences.com/about/about-organizer 0.9 https://cancer.miconferences.com/program/scientific-topics 0.9 https://cancer.miconferences.com/abstract-submission 0.9 https://cancer.miconferences.com/city-attractions 0.9 https://cancer.miconferences.com/register 0.9 https://cancer.miconferences.com/contact 0.9 https://cancer.miconferences.com/support-journal/mathews-journal-of-cancer-science 0.9 https://cancer.miconferences.com/privacy-policy 0.9 https://cancer.miconferences.com/terms-and-conditions 0.9 https://cancer.miconferences.com/organizing-committee/2026 0.8 https://cancer.miconferences.com/organizing-committee/2025 0.8 https://cancer.miconferences.com/speakers/2026 2026-04-03 0.8 https://cancer.miconferences.com/speakers/2025 2026-04-03 0.8 https://cancer.miconferences.com/speaker/sergey-suchkov 0.8 https://cancer.miconferences.com/speaker/henrique-manuel-dos-santos-faneca 0.8 https://cancer.miconferences.com/speaker/yan-shen-shan 0.8 https://cancer.miconferences.com/speaker/julia-sidorova 0.8 https://cancer.miconferences.com/speaker/rajvir-dahiya 0.8 https://cancer.miconferences.com/speaker/thomas-j-webster 0.8 https://cancer.miconferences.com/speaker/ren-wang-peng 0.8 https://cancer.miconferences.com/speaker/janusz-rak 0.8 https://cancer.miconferences.com/speaker/davoud-shojaeizadeh 0.8 https://cancer.miconferences.com/speaker/tenghua-yu 0.8 https://cancer.miconferences.com/speaker/bep-dhaliwal 0.8 https://cancer.miconferences.com/speaker/nabhan-linda 0.8 https://cancer.miconferences.com/speaker/salah-s-massoud 0.8 https://cancer.miconferences.com/speaker/constantinos-m-mikelis 0.8 https://cancer.miconferences.com/speaker/alain-chapel 0.8 https://cancer.miconferences.com/speaker/paulo-cesar-de-morais 0.8 https://cancer.miconferences.com/speaker/sergey-reva 0.8 https://cancer.miconferences.com/speaker/xue-xiao 0.8 https://cancer.miconferences.com/speaker/peng-bai 0.8 https://cancer.miconferences.com/speaker/minoo-shahidi 0.8 https://cancer.miconferences.com/speaker/chanda-siddoo-atwal 0.8 https://cancer.miconferences.com/speaker/viacheslav-artyushenko 0.8 https://cancer.miconferences.com/speaker/marika-crohns 0.8 https://cancer.miconferences.com/speaker/chia-jung-li 0.8 https://cancer.miconferences.com/speaker/subhash-c-kundu 0.8 https://cancer.miconferences.com/speaker/dmitri-lapotko 0.8 https://cancer.miconferences.com/speaker/viviana-c-blank 0.8 https://cancer.miconferences.com/speaker/biliana-nikolova 0.8 https://cancer.miconferences.com/speaker/nira-ben-jonathan 0.8 https://cancer.miconferences.com/speaker/k-r-muralidhar 0.8 https://cancer.miconferences.com/speaker/yacob-mathai-kunnathazhath 0.8 https://cancer.miconferences.com/speaker/alexandru-calin-grigorescu 0.8 https://cancer.miconferences.com/speaker/shadma-fatima 0.8 https://cancer.miconferences.com/speaker/zheng-weihui 0.8 https://cancer.miconferences.com/speaker/jianghao-ren 0.8 https://cancer.miconferences.com/speaker/anu-jose 0.8 https://cancer.miconferences.com/speaker/cheol-min-lee 0.8 https://cancer.miconferences.com/speaker/eleni-petsalaki 0.8 https://cancer.miconferences.com/speaker/anyou-wang 0.8 https://cancer.miconferences.com/speaker/saba-beigh 0.8 https://cancer.miconferences.com/speaker/zare-hamed 0.8 https://cancer.miconferences.com/speaker/dharmendra-kumar 0.8 https://cancer.miconferences.com/speaker/sebastiano-venturi 0.8 https://cancer.miconferences.com/speaker/stephan-bodis 0.8 https://cancer.miconferences.com/speaker/iveta-herichov 0.8 https://cancer.miconferences.com/speaker/chujie-li 0.8 https://cancer.miconferences.com/speaker/debi-lynn 0.8 https://cancer.miconferences.com/speaker/sarantis-gagos 0.8 https://cancer.miconferences.com/speaker/aurelian-udristioiu 0.8 https://cancer.miconferences.com/speaker/gaurav-vishal 0.8 https://cancer.miconferences.com/speaker/nicola-sarandria 0.8 https://cancer.miconferences.com/speaker/lorent-sijarina 0.8 https://cancer.miconferences.com/speaker/fatlinda-berisha 0.8 https://cancer.miconferences.com/speaker/liburn-grabovci 0.8 https://cancer.miconferences.com/speaker/omar-mohammad-alqaisi 0.8 https://cancer.miconferences.com/speaker/patricia-tai 0.8 https://cancer.miconferences.com/speaker/tanja-obradovic 0.8 https://cancer.miconferences.com/speaker/yasmeen-idrees 0.8 https://cancer.miconferences.com/speaker/can-k-k 0.8 https://cancer.miconferences.com/speaker/melinda-hysenaj 0.8 https://cancer.miconferences.com/speaker/huynh-yen-phi 0.8 https://cancer.miconferences.com/speaker/drilon-bytyci 0.8 https://cancer.miconferences.com/speaker/karishma-shelley 0.8 https://cancer.miconferences.com/speaker/prema-naittee-george 0.8 https://cancer.miconferences.com/speaker/mahwish-fatima 0.8 https://cancer.miconferences.com/speaker/melisa-stublla 0.8 https://cancer.miconferences.com/speaker/abir-biswas 0.8 https://cancer.miconferences.com/speaker/shanza-waseem 0.8 https://cancer.miconferences.com/speaker/ling-yin 0.8 https://cancer.miconferences.com/speaker/saba-bei 0.8 https://cancer.miconferences.com/speaker/yin-liu 0.8 https://cancer.miconferences.com/speaker/jialiang-chen 0.8 https://cancer.miconferences.com/speaker/el-gewely-mohamed-raafat 0.8 https://cancer.miconferences.com/speaker/vladan-radosavljevic 0.8 https://cancer.miconferences.com/speaker/delacour-delphine 0.8 https://cancer.miconferences.com/speaker/yuxuan-li 0.8 https://cancer.miconferences.com/speaker/li-jinze 0.8 https://cancer.miconferences.com/program/scientific-program/2026 2026-04-03 0.8 https://cancer.miconferences.com/program/scientific-program/2025 2025-11-14 0.8 https://cancer.miconferences.com/program/scientific-program/2026/anti-cancer-nanomedicine-in-humans-a-review-and-future-directions 0.8 https://cancer.miconferences.com/program/scientific-program/2026/personalized-and-precision-medicine-ppm-through-the-view-of-biodesign-inspired-translational-research-an-option-for-clinical-oncologists-caregiv-ers-and-consumers-to-secure-the-human-biosafety 0.8 https://cancer.miconferences.com/program/scientific-program/2026/precision-oncology-strategy-for-cancer-care-team-developing-targeted-cancer-therapy-advancing-personalized-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2026/iodine-and-caesium-137-angels-and-demons-of-evolutionary-biology-in-pancreatic-cancer-and-diabetes 0.8 https://cancer.miconferences.com/program/scientific-program/2026/precision-oncology-in-gynecologic-cancers-molecular-taxonomy-biomarker-guided-therapeutics-and-the-challenge-of-therapeutic-resistance 0.8 https://cancer.miconferences.com/program/scientific-program/2026/polyphyllin-d-inhibits-chaperone-mediated-autophagy-by-targeting-the-hsc70-lamp2a-interaction-in-non-small-cell-lung-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2026/integrative-analysis-reveals-immune-heterogeneity-and-immune-regulatory-genes-in-kras-mutant-lung-adenocarcinoma 0.8 https://cancer.miconferences.com/program/scientific-program/2026/prospecting-fluorine-doped-graphene-in-photodynamic-therapy 0.8 https://cancer.miconferences.com/program/scientific-program/2026/non-stationary-external-energy-mechanisms-in-cancer-diagnostics-and-treatment 0.8 https://cancer.miconferences.com/program/scientific-program/2026/how-to-chose-right-clinical-research-organization-cro-partner-when-developing-new-cancer-drug-while-meeting-challenges-of-current-critical-trends-in-oncology-drug-development 0.8 https://cancer.miconferences.com/program/scientific-program/2026/a-new-universal-fever-definition-and-the-unscientific-nature-of-the-conservative-fever-definition 0.8 https://cancer.miconferences.com/program/scientific-program/2026/targeting-hspd1-attenuates-neuroinflammation-and-promotes-functional-recovery-after-intracerebral-hemorrhage 0.8 https://cancer.miconferences.com/program/scientific-program/2026/molecular-disruption-of-pulmonary-surfactant-proteins-by-airborne-pollutants-an-integrative-in-silico-toxicology-approach 0.8 https://cancer.miconferences.com/program/scientific-program/2026/real-world-cancer-pain-incidence-and-treatment-in-daily-hospital 0.8 https://cancer.miconferences.com/program/scientific-program/2026/non-coplanar-volumetric-modulated-arc-therapy-for-brain-tumours-using-an-o-ring-gantry-linear-accelerator-a-dosimetric-evaluation 0.8 https://cancer.miconferences.com/program/scientific-program/2026/assessing-human-exposure-to-key-chemical-carcinogens-diagnostic-approaches-and-interpretation 0.8 https://cancer.miconferences.com/program/scientific-program/2026/radosavljevic-urinary-screening-biomarkers-of-the-key-chemical-carcinogens-for-bladder-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2026/decoding-intestinal-crypt-morphogenesis-from-tissue-mechanics-to-tumor-initiation 0.8 https://cancer.miconferences.com/program/scientific-program/2026/the-small-gtpase-rhoa-regulates-the-endothelial-barrier-during-metastasis 0.8 https://cancer.miconferences.com/program/scientific-program/2026/effect-of-posaconazole-compared-to-other-antifungal-drugs-in-survival-prevention-of-infection-in-patients-with-haematological-malignancy-a-systematic-review 0.8 https://cancer.miconferences.com/program/scientific-program/2026/nk-cell-associated-longnon-coding-rnas-reveal-heterogeneity-of-colorectalcancer-immune-microenvironment 0.8 https://cancer.miconferences.com/program/scientific-program/2026/nk-cell-associated-lncrna-signature-predicts-prognosis-and-immune-landscape-in-hepatocellular-carcinoma 0.8 https://cancer.miconferences.com/program/scientific-program/2025/personalized-and-precision-medicine-ppm-through-the-view-of-biodesign-inspired-translational-research-an-option-for-clinical-oncologists-caregivers-and-consumers-to-realize-the-potential-of-genomics-informed-care-to-secure-the-human-biosafety 0.8 https://cancer.miconferences.com/program/scientific-program/2025/3d-in-vitro-cancer-models-using-natural-biomaterials-for-studying-the-cancer-microenvironment-and-drug-screening 0.8 https://cancer.miconferences.com/program/scientific-program/2025/hypoxia-fibrosis-cycle-in-pancreatic-cancer-reveals-potential-pathways-associated-with-tumor-progression-and-predicts-poor-prognosis 0.8 https://cancer.miconferences.com/program/scientific-program/2025/anti-cancer-nanomedicine-in-humans-30-000-successful-cases-and-counting 0.8 https://cancer.miconferences.com/program/scientific-program/2025/copper-ii-complexes-as-potent-chemotherapeutic-agents-for-anticancer-therapy 0.8 https://cancer.miconferences.com/program/scientific-program/2025/lactate-dehydrogenase-b-noncanonically-promotes-ferroptosis-defense-in-kras-driven-lung-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/suppression-of-breast-cancer-by-small-molecules-that-block-the-prolactin-receptor 0.8 https://cancer.miconferences.com/program/scientific-program/2025/immunological-markers-as-predictors-of-unfavorable-pathomorphological-characteristics-an-upgrading-upstaging-and-risk-group-increase-in-prostate-cancer-patients-after-radical-prostatectomy 0.8 https://cancer.miconferences.com/program/scientific-program/2025/monoher-as-a-selective-radiosensitizer-in-breast-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/personalized-and-precision-oncology-ppo-to-be-set-up-via-precision-oncology-strategy-for-cancer-care-team-developing-targeted-cancer-therapy-advancing-personalized-cancer-care 0.8 https://cancer.miconferences.com/program/scientific-program/2025/targeting-glioblastoma-multiforme-through-a-multifaceted-therapeutic-drug-approach 0.8 https://cancer.miconferences.com/program/scientific-program/2025/key-mechanisms-driving-extravillous-trophoblast-lineage-imbalance-in-placenta-accreta-spectrum 0.8 https://cancer.miconferences.com/program/scientific-program/2025/the-controversy-of-radioactive-cesium-damage-on-animal-pancreas-and-diabetes 0.8 https://cancer.miconferences.com/program/scientific-program/2025/functional-integration-of-the-atp-synthasome-drives-mitochondrial-efficiency-in-breast-carcinoma 0.8 https://cancer.miconferences.com/program/scientific-program/2025/targeting-oral-squamous-cell-carcinoma-with-thienopyrimidines 0.8 https://cancer.miconferences.com/program/scientific-program/2025/targeting-sirt7-mediated-dna-damage-repair-as-a-novel-strategy-in-pancreatic-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/effectiveness-of-smoking-cessation-interventions-for-smokers-undergoing-lung-cancer-screening-a-systematic-review-and-meta-analysis 0.8 https://cancer.miconferences.com/program/scientific-program/2025/the-impact-of-social-marketing-based-intervention-on-educating-esophageal-cancer-preventive-behaviors 0.8 https://cancer.miconferences.com/program/scientific-program/2025/physical-activity-in-endometrial-cancer-prevention-and-control-bridging-epidemiological-evidence-to-molecular-mechanisms 0.8 https://cancer.miconferences.com/program/scientific-program/2025/targeted-nanosystems-to-mediate-combined-cancer-therapy 0.8 https://cancer.miconferences.com/program/scientific-program/2025/information-leakage-types-remedies-and-open-problems 0.8 https://cancer.miconferences.com/program/scientific-program/2025/cell-viability-assays-under-radiofrequency-application-modulated-by-nanomaterials 0.8 https://cancer.miconferences.com/program/scientific-program/2025/a-novel-mrna-genomic-technology-for-precision-medicine-cancer-diagnosis-prognosis-treatment-follow-up 0.8 https://cancer.miconferences.com/program/scientific-program/2025/resveratrol-reduces-the-presence-of-extracellular-traps-ets-in-acute-promyelocytic-leukemia-nb4-cells 0.8 https://cancer.miconferences.com/program/scientific-program/2025/gper-driven-crosstalk-in-breast-cancer-bridging-drugs-resistance-and-tumor-microenvironment-remodeling 0.8 https://cancer.miconferences.com/program/scientific-program/2025/preclinical-study-on-new-parathyroid-recognition-technology-in-thyroid-surgery 0.8 https://cancer.miconferences.com/program/scientific-program/2025/global-trends-and-predictive-factors-of-prophylactic-mastectomy-in-women-a-systematic-review-and-meta-analysis 0.8 https://cancer.miconferences.com/program/scientific-program/2025/from-experimental-research-to-clinical-trial-in-the-treatment-of-complication-of-radiotherapy-by-stem-cells 0.8 https://cancer.miconferences.com/program/scientific-program/2025/is-artificial-intelligence-a-possible-solution-for-challenges-in-healthcare 0.8 https://cancer.miconferences.com/program/scientific-program/2025/the-regulatory-role-of-endothelial-rhoa-on-tumor-microenvironment 0.8 https://cancer.miconferences.com/program/scientific-program/2025/applying-the-concept-of-lean-management-evaluation-of-a-pioneer-off-site-injection-program-for-androgen-deprivation-treatment-of-prostate-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/the-paradox-of-spirituality-its-impact-on-social-wellbeing-in-aya-cancer-survivors 0.8 https://cancer.miconferences.com/program/scientific-program/2025/innovative-fiber-solutions-for-cancer-diagnostics 0.8 https://cancer.miconferences.com/program/scientific-program/2025/immunotherapy-in-merkel-cell-carcinoma-of-the-skin-a-2025-comprehensive-review 0.8 https://cancer.miconferences.com/program/scientific-program/2025/application-of-crispr-cas9-technology-in-the-treatment-of-chronic-lymphocytic-leukemia-with-tp53-mutations 0.8 https://cancer.miconferences.com/program/scientific-program/2025/a-narrative-review-on-the-roles-of-nursing-in-sexual-dysfunction-among-oncological-patients-with-updated-recommendations 0.8 https://cancer.miconferences.com/program/scientific-program/2025/managing-sexual-issues-in-melanoma-patients-a-scoping-review 0.8 https://cancer.miconferences.com/program/scientific-program/2025/oncology-nurses-attitudes-knowledge-and-practices-in-providing-sexuality-care-to-cancer-patients-a-scoping-review 0.8 https://cancer.miconferences.com/program/scientific-program/2025/theory-and-perspective-big-data-and-artificial-intelligence-accelerate-the-pursuit-of-a-universal-cancer-principle-opportunities-and-challenges 0.8 https://cancer.miconferences.com/program/scientific-program/2025/instant-high-sensitivity-non-invasive-in-vivo-diagnosis-during-biopsy 0.8 https://cancer.miconferences.com/program/scientific-program/2025/beyond-survival-the-silent-struggle-of-living-after-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/is-cancer-theory-incomplete 0.8 https://cancer.miconferences.com/program/scientific-program/2025/strategic-development-of-novel-cancer-immunotherapies-medical-strategy-toward-regulatory-success 0.8 https://cancer.miconferences.com/program/scientific-program/2025/extracellular-vesicle-pathways-as-regulators-of-tumor-vascular-interactions-in-glioblastoma 0.8 https://cancer.miconferences.com/program/scientific-program/2025/anticancer-effect-of-patuletin-on-neuroblastoma-cell-line-sh-sy5y 0.8 https://cancer.miconferences.com/program/scientific-program/2025/cardiac-coherence-a-new-approach-to-oncology-medicine 0.8 https://cancer.miconferences.com/program/scientific-program/2025/time-and-cost-to-healthcare-providers-and-sites-associated-with-preparation-and-administration-of-subcutaneous-vs-intravenous-nivolumab-for-the-treatment-of-cancer-a-time-driven-activity-based-costing-study 0.8 https://cancer.miconferences.com/program/scientific-program/2025/intelligent-oncology-the-transformative-role-of-ai-in-the-future-of-cancer-research-and-care 0.8 https://cancer.miconferences.com/program/scientific-program/2025/targeting-alternative-lengthening-of-telomeres-in-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/association-between-lung-cancer-and-prostate-cancer-3-studied-cases-short-literature-review 0.8 https://cancer.miconferences.com/program/scientific-program/2025/an-eternal-moment-a-patients-feedback-to-medical-care-givers 0.8 https://cancer.miconferences.com/program/scientific-program/2025/dr-nicola-sarandria-s-theory-of-arginase-1-and-n2-neutrophil-s-role-in-rectal-cancer-based-on-the-2025-or1-research-study-directed-by-dr-nicola-sarandria-new-insights-on-the-relationship-between-arginase-1-tumor-associated-neutrophils-perineural-invasion-neoadjuvant-therapy-and-prognosis-in-rectal-cancer-patients 0.8 https://cancer.miconferences.com/program/scientific-program/2025/the-power-of-trust-through-the-eyes-of-a-patient 0.8 https://cancer.miconferences.com/program/scientific-program/2025/daily-profile-in-mirna-expression-in-the-colon-and-their-role-in-colorectal-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/expanding-the-reach-integrating-ai-generated-auto-contours-via-deep-learning-segmentation-into-diverse-treatment-planning-systems 0.8 https://cancer.miconferences.com/program/scientific-program/2025/comprehensive-pharmacokinetic-profiling-and-molecular-docking-analysis-of-natural-bioactive-compounds-targeting-oncogenic-biomarkers-in-breast-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/nanoparticle-based-therapeutic-platforms-development-and-evaluation-for-cancer-treatment 0.8 https://cancer.miconferences.com/program/scientific-program/2025/difficult-to-manage-prostate-cancer-scenarios-illustrating-the-pathologist-s-role-two-case-reports 0.8 https://cancer.miconferences.com/program/scientific-program/2025/overview-of-psma-pet-and-salvage-treatment-of-previously-irradiated-recurrent-prostate-cancers 0.8 https://cancer.miconferences.com/program/scientific-program/2025/updates-on-prostate-cancer 0.8 https://cancer.miconferences.com/program/scientific-program/2025/improving-quality-of-life-among-cancer-patients-in-the-modern-era 0.8 https://cancer.miconferences.com/program/scientific-program/2025/synergistic-antitumor-effects-of-2nf-and-safingol-combination-in-breast-cancer-molecular-mechanisms-involving-sphk1-mapks-and-er-stress 0.8 https://cancer.miconferences.com/program/scientific-program/2025/analysis-of-64-cases-of-oral-squamous-cell-carcinoma-of-the-buccal-mucosa 0.8 https://cancer.miconferences.com/program/scientific-program/2025/a-new-tension-sensitive-signaling-pathway-involving-polymerization-of-actin-prevents-chromatin-bridge-breakage-in-cytokinesis-in-human-cancer-cells 0.8 https://cancer.miconferences.com/program/scientific-program/2025/how-can-developing-countries-improve-survival-rates-of-glioma-patients 0.8 https://cancer.miconferences.com/program/scientific-program/2025/updates-on-cns-tumors 0.8 https://cancer.miconferences.com/program/scientific-program/2025/the-transcriptional-regulator-prdm1-key-insights-into-its-role-in-nk-cell-homeostasis-and-malignancy 0.8 https://cancer.miconferences.com/program/scientific-program/2025/oncologic-emergencies-a-narrative-review-with-expert-opinions-and-latest-recommendations 0.8 https://cancer.miconferences.com/program/scientific-program/2025/improving-survival-rates-of-glioma-patients-in-developing-countries 0.8 https://cancer.miconferences.com/program/scientific-program/2025/well-differentiated-liposarcoma-of-face-an-unusual-case-report 0.8 https://cancer.miconferences.com/program/scientific-program/2025/investigating-the-combined-effects-of-paclitaxel-and-pirfenidone-on-metastasis-in-triple-negative-breast-cancer-tnbc-cells 0.8 https://cancer.miconferences.com/program/scientific-program/2025/colorectal-cancer-screening 0.8 https://cancer.miconferences.com/program/scientific-topics/types-of-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-detection-and-diagnosis 0.9 https://cancer.miconferences.com/program/scientific-topics/prevention-and-epidemiology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-drugs-vaccines-and-drug-development 0.9 https://cancer.miconferences.com/program/scientific-topics/case-reports 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-treatments 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-genetics-and-genomics 0.9 https://cancer.miconferences.com/program/scientific-topics/palliative-care-and-supportive-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-research-and-clinical-trials 0.9 https://cancer.miconferences.com/program/scientific-topics/survivorship-and-long-term-care 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/next-generation-technologies-in-oncology-ai-big-data-digital-health-and-bioinformatics 0.9 https://cancer.miconferences.com/program/scientific-topics/future-directions-in-cancer-research 0.9 https://cancer.miconferences.com/program/scientific-topics/early-detection-of-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/acute-lymphoblastic-leukemia 0.9 https://cancer.miconferences.com/program/scientific-topics/acute-myeloid-leukemia 0.9 https://cancer.miconferences.com/program/scientific-topics/adaptive-radiotherapy 0.9 https://cancer.miconferences.com/program/scientific-topics/adolescent-and-young-adult-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/adrenal-tumors 0.9 https://cancer.miconferences.com/program/scientific-topics/advanced-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/anal-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/anaplastic-thyroid-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/appendiceal-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/artificial-intelligence-in-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/basal-cell-carcinoma 0.9 https://cancer.miconferences.com/program/scientific-topics/b-cell-malignancies 0.9 https://cancer.miconferences.com/program/scientific-topics/behavioral-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/big-data-in-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/biliary-tract-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/biomarkers 0.9 https://cancer.miconferences.com/program/scientific-topics/bladder-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/bone-and-soft-tissue-sarcomas 0.9 https://cancer.miconferences.com/program/scientific-topics/bone-marrow-transplantation 0.9 https://cancer.miconferences.com/program/scientific-topics/bone-tumors 0.9 https://cancer.miconferences.com/program/scientific-topics/brachytherapy 0.9 https://cancer.miconferences.com/program/scientific-topics/brain-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/brain-metastases 0.9 https://cancer.miconferences.com/program/scientific-topics/brain-tumor-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-bioinformatics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-cachexia 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-computational-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-data-analytics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-diagnostics-innovation 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-drug-discovery-and-development 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-drug-resistance 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-epidemiology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-epigenetics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-evolution 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-health-economics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-heterogeneity 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-imaging 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-immunology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-immunotherapy 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-metabolism 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-metabolomics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-metastasis 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-molecular-pathology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-nanotechnology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-population-sciences 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-proteomics-proteogenomics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-radiotherapy 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-rehabilitation 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-stem-cells 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-systems-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-therapeutics 0.9 https://cancer.miconferences.com/program/scientific-topics/cancer-vaccines 0.9 https://cancer.miconferences.com/program/scientific-topics/cardio-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/car-t-therapy 0.9 https://cancer.miconferences.com/program/scientific-topics/castration-resistant-prostate-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/cellular-therapy 0.9 https://cancer.miconferences.com/program/scientific-topics/cervical-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/cervical-cancer-screening-prevention 0.9 https://cancer.miconferences.com/program/scientific-topics/childhood-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/cholangiocarcinoma 0.9 https://cancer.miconferences.com/program/scientific-topics/chondrosarcoma 0.9 https://cancer.miconferences.com/program/scientific-topics/chronic-lymphocytic-leukemia 0.9 https://cancer.miconferences.com/program/scientific-topics/circulating-tumor-cells-dna 0.9 https://cancer.miconferences.com/program/scientific-topics/clinical-molecular-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/clonal-evolution-in-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/cns-metastases 0.9 https://cancer.miconferences.com/program/scientific-topics/colorectal-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/computational-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/cutaneous-lymphoma 0.9 https://cancer.miconferences.com/program/scientific-topics/cutaneous-melanoma 0.9 https://cancer.miconferences.com/program/scientific-topics/dendritic-cell-vaccines 0.9 https://cancer.miconferences.com/program/scientific-topics/differentiated-thyroid-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/diffuse-large-b-cell-lymphoma 0.9 https://cancer.miconferences.com/program/scientific-topics/digestive-cancers 0.9 https://cancer.miconferences.com/program/scientific-topics/digital-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/ductal-carcinoma-in-situ 0.9 https://cancer.miconferences.com/program/scientific-topics/endocrine-tumors 0.9 https://cancer.miconferences.com/program/scientific-topics/endometrial-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/environmental-carcinogenesis 0.9 https://cancer.miconferences.com/program/scientific-topics/esophageal-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/ewing-sarcoma 0.9 https://cancer.miconferences.com/program/scientific-topics/exercise-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/experimental-cancer-medicine 0.9 https://cancer.miconferences.com/program/scientific-topics/experimental-therapeutics 0.9 https://cancer.miconferences.com/program/scientific-topics/fallopian-tube-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/follicular-lymphoma 0.9 https://cancer.miconferences.com/program/scientific-topics/functional-tumor-imaging 0.9 https://cancer.miconferences.com/program/scientific-topics/gallbladder-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/gastric-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/gastroenteropancreatic-neuroendocrine-tumors 0.9 https://cancer.miconferences.com/program/scientific-topics/gastrointestinal-cancers 0.9 https://cancer.miconferences.com/program/scientific-topics/genitourinary-cancers 0.9 https://cancer.miconferences.com/program/scientific-topics/geriatric-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/germ-cell-tumors 0.9 https://cancer.miconferences.com/program/scientific-topics/gestational-trophoblastic-disease 0.9 https://cancer.miconferences.com/program/scientific-topics/glioblastoma 0.9 https://cancer.miconferences.com/program/scientific-topics/gynecologic-cancer-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/head-and-neck-cancers 0.9 https://cancer.miconferences.com/program/scientific-topics/heavy-ion-therapy 0.9 https://cancer.miconferences.com/program/scientific-topics/hematologic-cancer-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/hepatocellular-carcinoma 0.9 https://cancer.miconferences.com/program/scientific-topics/her2-positive-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/hodgkin-lymphoma 0.9 https://cancer.miconferences.com/program/scientific-topics/hormone-receptor-positive-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/hormone-sensitive-prostate-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/hyperthermic-intraperitoneal-chemotherapy 0.9 https://cancer.miconferences.com/program/scientific-topics/image-guided-radiotherapy 0.9 https://cancer.miconferences.com/program/scientific-topics/immuno-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/inflammatory-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/integrative-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/invasive-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/kidney-cancer-research-therapy 0.9 https://cancer.miconferences.com/program/scientific-topics/laryngeal-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/leptomeningeal-disease 0.9 https://cancer.miconferences.com/program/scientific-topics/leukemia 0.9 https://cancer.miconferences.com/program/scientific-topics/liquid-biopsy-in-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/liver-cancer-biology 0.9 https://cancer.miconferences.com/program/scientific-topics/lobular-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/localized-prostate-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/lung-adenocarcinoma 0.9 https://cancer.miconferences.com/program/scientific-topics/lung-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/lymphoid-malignancies 0.9 https://cancer.miconferences.com/program/scientific-topics/machine-learning-in-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/male-breast-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/malignant-lymphoma 0.9 https://cancer.miconferences.com/program/scientific-topics/mantle-cell-lymphoma 0.9 https://cancer.miconferences.com/program/scientific-topics/medical-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/medullary-thyroid-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/medulloblastoma 0.9 https://cancer.miconferences.com/program/scientific-topics/melanoma-research 0.9 https://cancer.miconferences.com/program/scientific-topics/merkel-cell-carcinoma 0.9 https://cancer.miconferences.com/program/scientific-topics/metastasis-research 0.9 https://cancer.miconferences.com/program/scientific-topics/minimal-residual-disease 0.9 https://cancer.miconferences.com/program/scientific-topics/molecular-carcinogenesis 0.9 https://cancer.miconferences.com/program/scientific-topics/molecular-targets 0.9 https://cancer.miconferences.com/program/scientific-topics/myelodysplastic-syndromes 0.9 https://cancer.miconferences.com/program/scientific-topics/myeloma 0.9 https://cancer.miconferences.com/program/scientific-topics/myeloproliferative-disorders 0.9 https://cancer.miconferences.com/program/scientific-topics/nanomedicine-in-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/nasopharyngeal-carcinoma 0.9 https://cancer.miconferences.com/program/scientific-topics/neuroendocrine-neoplasms 0.9 https://cancer.miconferences.com/program/scientific-topics/neuro-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/non-small-cell-lung-cancer 0.9 https://cancer.miconferences.com/program/scientific-topics/nuclear-medicine-in-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/nuclear-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/ocular-oncology 0.9 https://cancer.miconferences.com/program/scientific-topics/oncofertility 0.9 https://cancer.miconferences.com/program/scientific-topics/oncology-industry-partnering 0.9 https://cancer.miconferences.com/program/scientific-topics/oncology-informatics 0.9 https://cancer.miconferences.com/uploads/pdfs/tentative-program.pdf 0.8 https://cancer.miconferences.com/uploads/pdfs/cancer-2025-final-program.pdf 0.8 https://cancer.miconferences.com/uploads/pdfs/cancer-2025-abstract-book.pdf 0.8 https://cancer.miconferences.com/uploads/pdfs/final-program.pdf 0.8 https://cancer.miconferences.com/uploads/pdfs/conference-brochure.pdf 0.8 https://cancer.miconferences.com/uploads/pdfs/launch-announcement.pdf 0.8 https://cancer.miconferences.com/uploads/pdfs/abstract-submission-sample.docx 0.8